Moloney Securities Asset Management, LLC Northwest Biotherapeutics Inc Transaction History
Moloney Securities Asset Management, LLC
- $643 Million
- Q1 2024
A detailed history of Moloney Securities Asset Management, LLC transactions in Northwest Biotherapeutics Inc stock. As of the latest transaction made, Moloney Securities Asset Management, LLC holds 379,460 shares of NWBO stock, worth $163,167. This represents 0.03% of its overall portfolio holdings.
Number of Shares
379,460
Previous 358,160
5.95%
Holding current value
$163,167
Previous $250,000
21.2%
% of portfolio
0.03%
Previous 0.04%
Shares
17 transactions
Others Institutions Holding NWBO
# of Institutions
12Shares Held
625KCall Options Held
0Put Options Held
0-
Opus Capital Group, LLC60.2KShares$25,8640.0% of portfolio
-
Williams Jones Wealth Management, Llc. New York, NY40KShares$17,2000.0% of portfolio
-
Maripau Wealth Management LLC Fort Wayne, IN39.5KShares$16,9810.02% of portfolio
-
Ethos Financial Group, LLC King Of Prussia, PA23.7KShares$10,1910.0% of portfolio
-
Mai Capital Management20KShares$8,6000.0% of portfolio
About NORTHWEST BIOTHERAPEUTICS INC
- Ticker NWBO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,037,230,016
- Market Cap $446M
- Description
- Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, wh...